SBCVC logo

SBCVC

Asia, Shanghai, China, Shanghai

Description

SBCVC, formerly known as SoftBank China Venture Capital, is a prominent venture capital and private equity firm with a deep-rooted history in the Chinese investment landscape. Initially established as the China arm of SoftBank, the firm successfully spun out in 2016 to become an independent entity, retaining its strong market presence and investment expertise. Headquartered in Shanghai, SBCVC manages both USD and RMB-denominated funds, enabling it to cater to a diverse range of investment opportunities and investor preferences within China and globally. This strategic independence has allowed SBCVC to further solidify its position as a key player in the region's innovation ecosystem.

The firm primarily focuses on early to growth-stage investments across several high-growth sectors critical to China's economic development. Its core investment areas include Technology, Media, and Telecommunications (TMT), healthcare, clean energy, and consumer goods. SBCVC's investment philosophy emphasizes long-term value creation, partnering with ambitious entrepreneurs to scale their businesses and achieve market leadership. Their extensive experience and local insights provide portfolio companies with valuable strategic guidance and operational support, fostering sustainable growth.

SBCVC has built an impressive portfolio over its operational history, contributing significantly to the success of numerous industry leaders. The firm reportedly manages over $3 billion in assets across various funds, demonstrating its substantial financial capacity and influence. Typical first check sizes for SBCVC generally range from $5 million to $50 million, reflecting its flexibility to invest across different stages from Series A to later growth rounds. This broad range allows them to support promising startups from their initial commercialization phases through to significant market expansion, cementing their reputation as a versatile and impactful investor in the dynamic Chinese market.

Investor Profile

SBCVC has backed more than 29 startups, with 1 new investments in the last 12 months alone. The firm has led 6 rounds, about 21% of its total and boasts 17 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Series A rounds (top funding stages).
  • Majority of deals are located in China, United States, Australia.
  • Strong thematic focus on Software, Health Care, Information Technology.
  • Typical check size: $5M – $50M.

Stage Focus

  • Series C (21%)
  • Series B (21%)
  • Series A (17%)
  • Series Unknown (17%)
  • Seed (10%)
  • Series E (7%)
  • Private Equity (3%)
  • Angel (3%)

Country Focus

  • China (72%)
  • United States (17%)
  • Australia (7%)
  • Hong Kong (3%)

Industry Focus

  • Software
  • Health Care
  • Information Technology
  • Biotechnology
  • Cloud Computing
  • Medical
  • Semiconductor
  • E-commerce
  • Marketing
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SBCVC frequently co-invest with?

IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 2
GSR Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
Cowin Venture
Asia, Beijing, China, Beijing
Co-Investments: 2
Legend Capital
Asia, Beijing, China, Beijing
Co-Investments: 2
Yimei Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 3
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 2
WI Harper Group
North America, California, United States, San Francisco
Co-Investments: 2
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 2
Intel Capital
North America, California, United States, Santa Clara
Co-Investments: 3

Which angels does SBCVC often collaborate with?

DO
North America, United States
Shared Deals: 1
GM
North America, California, United States, Beverly Hills
Shared Deals: 1
PC
North America, California, United States, Redwood City
Shared Deals: 1
MK
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by SBCVC?

UCaize

Shanghai, Shanghai, China

UCaize is a biopharmaceutical developer that is engaged in the research and development of new drugs for the treatment of blood tumors.

BiopharmaHealth CareMedical
SeedFeb 26, 2025
Amount Raised: $11,019,284
TUNGEE

Guangzhou, Guangdong, China

Tungee is a professional sales intelligence solution provider.

Artificial Intelligence (AI)Machine LearningSalesService IndustrySoftware
Series BDec 15, 2021
Amount Raised: $47,113,512
Feiliu

Shanghai, Shanghai, China

Feiliu is a provider of enterprise supply chain management and optimization technology based on artificial intelligence.

Artificial Intelligence (AI)Information TechnologyLogisticsSoftwareSupply Chain Management
Series AMay 31, 2021
Amount Raised: $31,397,174
EDDA Technology

Princeton, New Jersey, United States

EDDA Technology offers computer assistance to the patient care management cycle and enables early detection and diagnosis of diseases.

3D TechnologyHealth CareHealth DiagnosticsInformation Technology
Private EquityApr 7, 2021
Amount Raised: $150,000,000
Corigine

Santa Clara, California, United States

Corigine delivers innovative solutions in connectivity, storage, and machine learning for cloud, automotive, and emerging applications.

Cloud ManagementMachine LearningSemiconductor
SeedMar 22, 2021
Amount Raised: $10,000,000
Tezign

Shanghai, Shanghai, China

Tezign is the contech startup in China aiming to build the digital infrastructure of content experience

AnimationContent MarketingGraphic DesignMarketingSaaSSoftware
Series CMar 18, 2021
Huilianyi

Putuo, Shanghai, China

Huilianyi is a business travel and expense reimbursement system developer based in China.

Travel
Series CMar 30, 2020
Amount Raised: $42,251,736
Taimei Technology

Jiaxing, Zhejiang, China

Taimei Technology provides a cloud platform for clinical research collaboration.

BiopharmaBiotechnologyClinical TrialsCloud ComputingMedicalPharmaceuticalSoftware
Series EOct 18, 2019
Amount Raised: $211,813,548
New Horizon Health

Hangzhou, Zhejiang, China

New Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes.

Big DataBiotechnologyHealth CareMedical
Series CMay 24, 2019
Amount Raised: $66,500,000
Taimei Technology

Jiaxing, Zhejiang, China

Taimei Technology provides a cloud platform for clinical research collaboration.

BiopharmaBiotechnologyClinical TrialsCloud ComputingMedicalPharmaceuticalSoftware
Series EJan 28, 2019
Amount Raised: $80,000,000